MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1507/endocrj.ej20-0762

Медицинская библиотека · Endocrine journal · 2021

Clinical features and outcomes of metastatic pheochromocytoma treated by cytotoxic chemotherapy.

Fujiwara Yu, Ohmoto Akihiro, Fukuda Naoki, Wang Xiaofei, Urasaki Tetsuya, Hayashi Naomi, Sato Yasuyoshi, Nakano Kenji, Yunokawa Mayu, Ono Makiko, Tomomatsu Junichi, Yuasa Takeshi, Yonese Junji, Takahashi Shunji

СтатьяПеревод в очереди

Аннотация

Cytotoxic chemotherapy, including cyclophosphamide, vincristine, and dacarbazine (CVD) therapy, is widely used to treat metastatic pheochromocytoma and paraganglioma. Because these diseases are rare, studies are needed to establish treatment strategies. This was a single-center and retrospective study to analyze the efficacy of chemotherapy for patients with metastatic pheochromocytoma and paraganglioma diagnosed in 1983-2020. Clinical characteristics, tumor volume response, biochemical response based on catecholamine level, overall survival, and progression-free survival were evaluated. Patients with a complete response or partial response in tumor volume or catecholamine level were classified as responders. Sixteen patients were administered chemotherapy for a median of 16.5 cycles (interquartile range, 10-42). The tumor volume response was classified as follows: partial response (N = 4), stable disease (N = 9), and progressive disease (N = 3) (disease control rate = 81%). The biochemical responses were as follows: complete response (N = 2), partial response (N = 5), no change (N = 3), and progressive disease (N = 1) (disease control rate = 91%). The 5-year survival rate was 50% (95% confidence interval [CI], 21-74%) and median overall survival was 4.4 years (95% CI, 2.4 years-not reached). Overall survival and progression-free survival between responders and nonresponders were not statistically different. One patient developed myelodysplastic syndrome during CVD therapy. In conclusion, chemotherapy achieved disease control among more than half of patients, although survival did not differ between responders and nonresponders. Further fundamental research and prospective trials are needed to analyze the efficacy of CVD therapy.

Для цитирования: Fujiwara Yu, Ohmoto Akihiro, Fukuda Naoki, Wang Xiaofei, Urasaki Tetsuya, Hayashi Naomi, Sato Yasuyoshi, Nakano Kenji, Yunokawa Mayu, Ono Makiko, Tomomatsu Junichi, Yuasa Takeshi, Yonese Junji, Takahashi Shunji. Clinical features and outcomes of metastatic pheochromocytoma treated by cytotoxic chemotherapy.. Endocrine journal. 2021. DOI: 10.1507/endocrj.ej20-0762.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.